keyword
https://read.qxmd.com/read/38653601/sensory-neuronal-control-of-skin-barrier-immunity
#1
REVIEW
Xinyi Feng, Haoting Zhan, Caroline L Sokol
Peripheral sensory neurons recognize diverse noxious stimuli, including microbial products and allergens traditionally thought to be targets of the mammalian immune system. Activation of sensory neurons by these stimuli leads to pain and itch responses as well as the release of neuropeptides that interact with their cognate receptors expressed on immune cells, such as dendritic cells (DCs). Neuronal control of immune cell function through neuropeptide release not only affects local inflammatory responses but can impact adaptive immune responses through downstream effects on T cell priming...
April 22, 2024: Trends in Immunology
https://read.qxmd.com/read/38652379/economic-burden-of-itch-related-sleep-loss-in-moderate-to-severe-atopic-dermatitis-in-the-united-kingdom
#2
JOURNAL ARTICLE
Evangeline J Pierce, Russel T Burge, Alex J Hirst, Aimée M Fox, Anu K Suokas, Yunni Yi
INTRODUCTION: Atopic dermatitis is associated with intense itch, which has been shown to cause sleep disruption that significantly impacts the lives of patients with atopic dermatitis. Despite this, little is known about its burden to the healthcare system and society. This study aimed to quantify the economic burden of itch-related sleep loss in moderate-to-severe atopic dermatitis in the UK. METHODS: A literature-based decision-analytic model was developed from a healthcare payer and societal perspective...
April 23, 2024: Dermatology and Therapy
https://read.qxmd.com/read/38651851/skin-changes-in-suspected-lyme-disease
#3
JOURNAL ARTICLE
Pero Vržogić, Ante Perica
Dear Editor, Ticks carry many diseases, bacteria, and viruses and represent a very important healthcare issue both in Croatia and globally. Although most ticks are not infected with pathogens dangerous to humans, some ticks can transmit infectious diseases with significant morbidity and mortality. This is caused by the increasing incidence of many tick-borne diseases over a growing geographical area. Many factors influence which species of ticks are present in a given geographical area, as well as the density of their population and the risk of human exposure to infected ticks...
December 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/38651075/assessment-of-the-effect-of-rehmannia-glutinosa-leaf-extract-in-maintaining-skin-health-a-proof-of-concept-double-blind-randomized-placebo-controlled-clinical-trial
#4
JOURNAL ARTICLE
Shalini Srivastava, Shu Fen Huang, Manjiri S Jagtap
PURPOSE: A double-blind, placebo-controlled, randomized, proof-of-concept trial aimed to evaluate the efficacy and safety of VerbasnolTM [ Rehmannia glutinosa Libosch leaf-based extract (RGLE)] in females, with moderate to severe acne vulgaris. PARTICIPANTS AND METHODS: Twenty-two females aged 18 to 35 years having moderate to severe acne with Global Acne Grading System (GAGS) scores of 19 to 38 were included in the study and were randomized in a 1:1 ratio to receive either one capsule (100 mg/day) of RGLE or placebo orally after breakfast for 56 days...
2024: Clinical, Cosmetic and Investigational Dermatology
https://read.qxmd.com/read/38647975/sustained-improvements-in-clinical-and-patient-reported-outcomes-and-quality-of-life-through-5%C3%A2-years-among-ixekizumab-treated-patients-with-complete-clearance-of-scalp-psoriasis-by-week-60
#5
JOURNAL ARTICLE
Alexander Egeberg, Jason E Hawkes, Najwa Somani, Russel Burge, Kyoungah See, Gaia Gallo, Missy McKean-Matthews, Melinda Gooderham, George Han, April Armstrong
INTRODUCTION: Ixekizumab, a high-affinity monoclonal antibody that selectively targets interleukin-17A, is approved for the treatment of moderate-to-severe plaque psoriasis. Since scalp psoriasis can be burdensome and challenging to treat with non-systemic therapies, this post hoc analysis focused on scalp psoriasis in patients with moderate-to-severe plaque psoriasis and baseline scalp involvement. The analysis considered a holistic concept of clearance through 5 years of ixekizumab treatment...
April 22, 2024: Dermatology and Therapy
https://read.qxmd.com/read/38639157/effects-of-a-brief-mindfulness-based-intervention-in-patients-with-psoriasis-a-randomized-controlled-trial
#6
RANDOMIZED CONTROLLED TRIAL
Markus Eckardt, Laura Stadtmueller, Christoph Zick, Jörg Kupfer, Christina Schut
Mindfulness is a special type of attention, namely focusing on the current moment in a non-judgmental manner. Extensive mindfulness-based interventions have been shown to have positive effects in patients with psoriasis. However, it is unclear whether brief (2-week) interventions are also beneficial. Therefore, the aim of this study was to investigate the effects of a 2-week mindfulness-based intervention in patients with psoriasis. Patients were randomly assigned to an experimental (treatment-as-usual + mindfulness-based intervention) or control group (treatment-as-usual) during their clinic stay...
April 19, 2024: Acta Dermato-venereologica
https://read.qxmd.com/read/38637696/spatial-modeling-connecting-childhood-atopic-dermatitis-prevalence-with-household-exposure-to-pollutants
#7
JOURNAL ARTICLE
Grace Ratley, Jordan Zeldin, Ashleigh A Sun, Manoj Yadav, Prem Prashant Chaudhary, Ian A Myles
BACKGROUND: Atopic dermatitis (AD) is a chronic, inflammatory disease characterized by dry, pruritic skin. In the U.S., the prevalence of AD has increased over three-fold since the 1970s. We previously reported a geographic association between isocyanate-containing air pollution and AD as well as mechanistic data demonstrating that isocyanates induce skin dysbiosis and activate the host itch receptor TRPA1. However, non-spatial models are susceptible to spatial confounding and may overlook other meaningful associations...
April 18, 2024: Commun Med (Lond)
https://read.qxmd.com/read/38637265/bee-venom-acupuncture-and-herbal-medicine-for-hand-eczema-two-case-reports-and-an-in-vivo-study
#8
JOURNAL ARTICLE
Soobin Jang, Hyo In Kim, Jae Woo Jung, Mina Boo, Soo-Hyun Sung, Jinbong Park, Sungha Kim
INTRODUCTION: Eczema and contact dermatitis are relatively common, non-life-threatening disease, but can reduce the patient's quality-of-life when it becomes chronic. This study describes two cases of bee venom acupuncture (BVA) and herbal medicine (San Wu Huangqin decoction; SWH) co-treatment for hand eczema and contact dermatitis, then confirms the effect of the combination therapy in an in vivo model of eczema. CASE PRESENTATION: A 56-year-old female (case 1) and a 33-year-old male (case 2) presented to the clinic with symptoms of itching and erythema (case 1), and scaliness (case 2) on both hands...
March 21, 2024: Explore: the Journal of Science and Healing
https://read.qxmd.com/read/38634699/burden-of-impaired-sleep-and-its-improvement-through-topical-treatment-in-psoriasis-and-atopic-dermatitis
#9
JOURNAL ARTICLE
Caroline Mann, Matthias Dreher, Jan-Niklas Rothschmidt, Petra Staubach
INTRODUCTION: Patients with chronic inflammatory skin diseases often suffer from sleep disturbances. However, objective data on sleep architecture, especially to evaluate potential overall influences under therapy, are lacking. PATIENTS AND METHODS: Pilot study on sleep quality changes including psoriasis and atopic dermatitis patients before and 2 weeks after intensive topical treatment. In addition to disease activity rating, patient-rated outcomes for itch severity and sleep quality and polygraphy was performed before and after topical therapy...
April 18, 2024: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/38631843/the-regulation-of-the-pd-1-pd-l1-pathway-in-imiquimod-induced-chronic-psoriasis-itch-and-itch-sensitization-in-mouse
#10
JOURNAL ARTICLE
Zhehao Xu, Yue Wang, Changcheng Jiang, Zhengwei Wang, Yongfeng Chen, Manli Fan
PD-1/PD-L1 inhibitors have been demonstrated to induce itch in both humans and experimental animals. However, whether the PD-1/PD-L1 pathway is involved in the regulation of chronic psoriatic itch remains unclear. This study aimed to investigate the role of the PD-1/PD-L1 pathway in imiquimod-induced chronic psoriatic itch. The intradermal injection of PD-L1 in the nape of neck significantly alleviated chronic psoriatic itch in imiquimod-treated skin. Additionally, we observed that spontaneous scratching behavior induced by imiquimod disappeared on day 21...
April 17, 2024: Molecular Pain
https://read.qxmd.com/read/38629497/efficacy-and-safety-of-nemolizumab-and-topical-corticosteroids-for-prurigo-nodularis-results-from-a-randomised-double-blind-placebo-controlled-phase-ii-iii-clinical-study-in-patients-aged-%C3%A2-13-years
#11
JOURNAL ARTICLE
Hiroo Yokozeki, Hiroyuki Murota, Takayo Matsumura, Hiroshi Komazaki
BACKGROUND: Prurigo nodularis, a chronic inflammatory skin condition, adversely affects the quality of life of affected individuals. Current treatment options for prurigo nodularis in Japan are limited. OBJECTIVES: To evaluate the optimal dose, efficacy, and safety of long-term treatment with nemolizumab in patients with prurigo nodularis in Japan. METHODS: In a 16-week, double-blind, phase II/III study, patients aged ≥13 years with prurigo nodularis were randomly assigned (1:1:1) to nemolizumab 30 mg, 60 mg, or placebo groups, with concomitant topical corticosteroids, every 4 weeks...
April 17, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38623100/an-interesting-case-of-macular-amyloidosis-with-no-significant-etiology
#12
Avni Gakkhar, Ashok M Mehendale, Shivansh Mehendale
Macular amyloidosis is primary localized cutaneous amyloidosis (PLCA). It is described by the extracellular accumulation of heterogenic amyloid proteins in the skin that does not affect the systemic immune system, causing hyperpigmented patches. It is a prevalent skin disorder of young female adults, especially in India, since it affects the population with darker skin. History of frictional rub on the skin is typically present, such as using loofah or bathing scrubs or stones. The case presented below is of a 23-year-old female who presented with a hyperpigmented patch on the upper back of both sides and extensor surface of arms and did not have any history of usage of loofah on those areas, compelling us to research more on the other causative factors (genetic predisposition, infectious agents, and UV radiation are probable causative factors) for macular amyloidosis...
March 2024: Curēus
https://read.qxmd.com/read/38621466/comparing-chinese-herbal-medicine-bath-therapy-with-topical-calcipotriol-for-psoriasis-vulgaris-a-systematic-review-with-meta-analysis-and-association-rule-analysis
#13
REVIEW
Junyue Wang, Claire Shuiqing Zhang, Anthony Lin Zhang, Charlie Changli Xue, Chuanjian Lu
ETHNOPHARMACOLOGICAL RELEVANCE: Psoriasis is a chronic inflammatory skin disease. Vitamin D analogues are the first-line topical agents for the long-term management of psoriasis. Chinese herbal medicine (CHM) bath therapy is commonly employed for psoriasis. However, the effects and safety of CHM bath therapy compared with topical calcipotriol for psoriasis vulgaris remain inconclusive. Furthermore, the combination of herbs, a distinctive feature of CHM, is essential for its therapeutic effects due to the individual and synergistic properties of the herbs involved...
April 13, 2024: Journal of Ethnopharmacology
https://read.qxmd.com/read/38621336/inhibition-of-macrophage-mapk-nf-%C3%AE%C2%BAb-pathway-and-th2-axis-by-mangiferin-ameliorates-mc903-induced-atopic-dermatitis
#14
JOURNAL ARTICLE
Cheng Lu, ShiJun Deng, YanJiao Liu, ShengJin Yang, DingMei Qin, LiJuan Zhang, Rui-Rui Wang, Yi Zhang
Available online Atopic dermatitis (AD) is a chronic, persistent inflammatory skin disease characterized by eczema-like lesions and itching. Although topical steroids have been reported for treating AD, they are associated with adverse effects. Thus, safer medications are needed for those who cannot tolerate these agents for long periods. Mangiferin (MAN) is a flavonoid widely found in many herbs, with significant anti-inflammatory and immunomodulatory activities. However, the potential modulatory effects and mechanisms of MAN in treating Th2 inflammation in AD are unknown...
April 14, 2024: International Immunopharmacology
https://read.qxmd.com/read/38616484/successful-treatment-of-dyshidrotic-palmoplantar-eczema-with-tralokinumab
#15
Nisha V Parmar, Anwar Al Hammadi
Dyshidrotic palmoplantar eczema or pompholyx is considered to be a part of the spectrum of atopic dermatitis with a significant impact on the quality of life and limited treatment options. Tralokinumab is a new fully human monoclonal antibody which neutralizes interleukin 13, a chief cytokine in itch pathogenesis and skin barrier defects. Tralokinumab is FDA-approved for the treatment of atopic dermatitis in adults and EMA-approved for the treatment of atopic dermatitis in adults and adolescents. We, hereby, report a 40-year-old female with severe dyshidrotic palmoplantar eczema who was successfully treated with tralokinumab...
April 14, 2024: Australasian Journal of Dermatology
https://read.qxmd.com/read/38616301/artificial-intelligence-based-prescription-of-personalized-scalp-cosmetics-improved-the-scalp-condition-efficacy-results-from-100-participants
#16
JOURNAL ARTICLE
Bo Ri Kim, Min Jae Kim, Jieun Koo, Hwa-Jung Choi, Kyung Ho Paik, Soon Hyo Kwon, Hye-Ryung Choi, Chang Hun Huh, Jung Won Shin, Dong-Sun Park, Jung-Im Na
Background: Scalp-related symptoms such as dandruff and itching are common with diverse underlying etiologies. We previously proposed a novel classification and scoring system for scalp conditions, called the scalp photographic index (SPI); it grades five scalp features using trichoscopic images with good reliability. However, it requires trained evaluators. Aim: To develop artificial intelligence (AI) algorithms for assessment of scalp conditions and to assess the feasibility of AI-based recommendations on personalized scalp cosmetics...
December 2024: Journal of Dermatological Treatment
https://read.qxmd.com/read/38615978/prelimbic-cortex-nucleus-accumbens-core-projection-positively-regulates-itch-and-itch-related-aversion
#17
JOURNAL ARTICLE
Jun-Hui Long, Pu-Jun Wang, Li Xuan, Yao Juan, Guang-Yan Wu, Jun-Fei Teng, Jian-Feng Sui, Ya-Min Li, Liu Yang, Hong-Li Li, Shu-Lei Liu
Itch is one of the most common clinical symptoms in patients with diseases of the skin, liver, or kidney, and it strongly triggers aversive emotion and scratching behavior. Previous studies have confirmed the role of the prelimbic cortex (Prl) and the nucleus accumbens core (NAcC), which are reward and motivation regulatory centers, in the regulation of itch. However, it is currently unclear whether the Prl-NAcC projection, an important pathway connecting these two brain regions, is involved in the regulation of itch and its associated negative emotions...
April 12, 2024: Behavioural Brain Research
https://read.qxmd.com/read/38615134/novel-topical-treatments-for-itch
#18
REVIEW
Rami H Mahmoud, Omar Mahmoud, Georgia Biazus Soares, Gil Yosipovitch
The experience of itch often poses a burden on patient quality of life and has the capacity to inflict significant suffering. Topical therapies are a mainstay of treatment for many cutaneous and systemic diseases and afford patients the opportunity to manage their conditions without many of the systemic side effects of non-topical therapies. We review a multitude of new topical medications targeting the skin, immune system, and neural receptors. The list includes Janus kinase inhibitors, tyrosine kinase inhibitors, phosphodiesterase inhibitors, transient receptor vanilloid inhibitors, topical cannabinoids, and topical acetaminophen...
April 13, 2024: Dermatology and Therapy
https://read.qxmd.com/read/38613531/beyond-the-surface-a-narrative-review-examining-the-systemic-impacts-of-recessive-dystrophic-epidermolysis-bullosa
#19
REVIEW
Courtney Popp, William Miller, Cindy Eide, Jakub Tolar, John A McGrath, Christen L Ebens
Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genetic disease resulting from inadequate type VII collagen (C7). Although recurrent skin blisters and wounds are the most apparent disease features, the impact of C7 loss is not confined to the skin and mucous membranes. RDEB is a systemic disease marred by chronic inflammation, fibrotic changes, pain, itch, and anemia, significantly impacting QOL and survival. In this narrative review, we summarize these systemic features of RDEB and promising research avenues to address them...
April 12, 2024: Journal of Investigative Dermatology
https://read.qxmd.com/read/38612578/liquiritin-carbomer-gel-cold-paste-promotes-healing-of-solar-dermatitis-in-mice
#20
JOURNAL ARTICLE
Yanfang Huang, Sijia Li, Jinghua Pan, Congjing Song, Weiqiang Chen, Yun Zhang
Ultraviolet radiation (UVR) has various effects on human cells and tissues, which can lead to a variety of skin diseases and cause inconvenience to people's lives. Among them, solar dermatitis is one of the important risk factors for malignant melanoma, so prevention and treatment of solar dermatitis is very necessary. Additionally, liquiritin (LQ) has anti-inflammatory effects. In this study, we aimed to evaluate the anti-inflammatory and pro-wound healing effects of liquiritin carbomer gel cold paste (LQ-CG-CP) in vitro and in vivo...
March 28, 2024: International Journal of Molecular Sciences
keyword
keyword
76637
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.